IJCEMR

Article http://dx.doi.org/10.26855/ijcemr.2024.04.016

Clinical Efficacy of Damol Injection Combined with Nimodipine in Cerebral Small Vascular Cognitive Dysfunction

TOTAL VIEWS: 341

Liyan Zhang, Wei Qin*

Department of Integrative Medicine, Affiliated Hospital of Hebei University, Baoding, Hebei, China.

*Corresponding author: Wei Qin

Published: May 24,2024

Abstract

Objective: To analyze the clinical efficacy of ginkgo damol injection combined with nimodipine in treating cerebral small vascular cognitive dysfunction. Methods: 73 patients with cerebral microvascular cognitive dysfunction admitted to our hospital from June 2022 to October 2023 were selected, which were divided into an observation group and a control group according to the case grouping method, with 36 cases and 37 cases, respectively. The observation group was treated with Ginkgo damol injection combined with nimodipine, and the control group compared the mental status (Brief Mental State Examination Scale, Mini-Mental State Examination, MMSE) and cognitive condition (Montreal Cognitive Assessment Scale, Montreal Cognitive Assessment, MoCA). Results: After treatment, mental status and cognitive status in both groups improved, while the observation group showed a more significant improvement trend, with statistically significant significance (P <0.05). Conclusion: Combined with nimodipine treatment can effectively improve their clinical efficacy and improve their cognitive status and mental state, which is worth promoting

References

[1] Ding yongmin. Analysis of the efficacy of nimodipine and oracetam in cerebral microvessel disease combined with cognitive dysfunction [J]. General Practice in China, 2020, 23 (S1): 170-172.

[2] Zhang Deta, Ge Jianhua, Ye Lisa, et al. Analysis of factors associated with vascular cognitive dysfunction caused by cerebral small vessel disease [J]. Chinese Journal of Practical Neurological Disorders, 2020, 23 (17): 1520-1524.

[3] Hou Xiaoshun, Zhu Dong-Asia. Progress in cerebral small vessel disease and its related cognitive dysfunction [J]. Journal of Nanjing Medical University (Natural Science Edition), 2020, 40 (6): 920-926.

[4] Koszewiczz M, Jaroch J, Brzecka A, et al. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment [J]. Pharmacological Research, 2020, 164(4):105277.

[5] Bai Jing, Zhu Xiaoyue, Li Feng. Progress in pathological cognitive dysfunction in small brain vessels [J]. Stroke and Neurological Diseases, 2021, 28 (1): 119-122.

[6] Hou Jinyi, Sun Juguang, Shi Jiangfeng, et al. Clinical study of patients with cerebral small vascular cognitive dysfunction [J]. Chinese Journal of Integrated Traditional Chinese and Western Medicine, 2019, 39 (11): 1336-1339.

How to cite this paper

Clinical Efficacy of Damol Injection Combined with Nimodipine in Cerebral Small Vascular Cognitive Dysfunction

How to cite this paper:  Liyan Zhang, Wei Qin. (2024) Clinical Efficacy of Damol Injection Combined with Nimodipine in Cerebral Small Vascular Cognitive DysfunctionInternational Journal of Clinical and Experimental Medicine Research8(2), 277-280.

DOI: http://dx.doi.org/10.26855/ijcemr.2024.04.016